Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Endocrinology
Disease Category: Diabetes Mellitus, Type 2
Trial Information
Are You a Type 2 Diabetic and Your Current Medications Are Just Not Enough?
You are invited to participate in a research study to further assess the safety and effectiveness of Welchol used as an add-on therapy to pioglitazone or pioglitazone in combination with either metformin or sulfonylurea in treating Type 2 Diabetes. Welchol has been shown to improve blood sugar control in people with Type 2 Diabetes who have inadequate glucose control while receiving other antidiabetic medications. If eligible you will receive, at no cost to you, the investigational medication, related physical exams and lab tests and diet counseling. You may also receive compensation for your participation!
Inclusion criteria: To participate you must be at least 18 years of age with a diagnosis of Type 2 Diabetes and have inadequate glycemic control on a stable dose of your current antidiabetic medication. Other than your Type 2 Diabetes, you must be clinically stable in regard to your medical conditions. Call our recruitment nurse to see if you qualify!
Exclusionary criteria include: history of Type 1 Diabetes; history of bowel obstruction, dysphagia, swallowing disorders, other gastrointestinal motility disorders or major GI surgery; history of insulin use for greater than two weeks duration during the previous three months or a total of greater than two months insulin therapy any time prior to screening.
Marilyn Lindell, LPN, Recruitment Nurse
Billings Clinic Research Center
1045 North 30th Street
Billings, MT 59101
Phone: (406) 247-6489 or toll free at (800) 996-2663
Fax: (406) 255-8479
EMail: research@billingsclinic.org
View Google Map
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
